Full name
POLIMED RESEARCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
18.1 - Printing and service activities related to printing
33.1 - Repair and maintenance of metal products, machinery, and equipment
33.2 - Installation of industrial machinery, equipment, and devices
58.1 - Publishing of books, newspapers, and periodicals, and other publishing activities, excluding software publishing
72.1 - Scientific research and development in natural and technical sciences
73.1 - Advertising
77.3 - Rental and leasing of other machinery, equipment, and tangible assets
85.5 - Non-school forms of education
45.1
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,4 | 0,3 | 1,4 | 374,4 |
EBITDA | 0,3 | 1,2 | 2,6 | 116,6 |
Short time liabilities | 6,7 | 6,3 | 3,1 | -50,8 |
Equity capital | 5,5 | 5,7 | 6,6 | 15,2 |
Operating profit (EBIT) | -0,1 | 0,7 | 1,5 | 130,7 |
Assets | 19 | 14,5 | 10,8 | -25,8 |
Net profit (loss) | -0,4 | 0,2 | 1 | 426 |
Cash | 5,3 | 1,1 | 0 | -96,8 |
Net income from sale | 27 | 17,3 | 15,8 | -8,7 |
Liabilities and provisions for liabilities | 13,5 | 8,8 | 4,2 | -52,5 |
Working assets | 15,7 | 10,5 | 7,7 | -26,6 |
Depreciation | 0,4 | 0,5 | 1,1 | 98,8 |
% | % | % | p.p. | |
Profitability of capital | -7,1 | 3,4 | 15,5 | 12,1 |
Equity capital to total assets | 29 | 39,4 | 61,1 | 21,7 |
Gross profit margin | -1,4 | 1,7 | 8,8 | 7,1 |
EBITDA Margin | 1,3 | 6,9 | 16,5 | 9,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 91 | 132 | 71 | -61 |
Current financial liquidity indicator | 1.3409185409545898 | 1.3690412044525146 | 2.417654037475586 | 1 |
Net dept to EBITDA | -1.4476258754730225 | 2.463709831237793 | 0.7991086840629578 | -1,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane